A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza

NCT01231620 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

626

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

DRUG: Zanamivir
DRUG: Placebo to match zanamivir
DRUG: Oseltamivir
DRUG: Placebo to match oseltamivir

Sponsor

GlaxoSmithKline